ArticleHepatology international2025

Reply to letter to the editor "Comment on: "Hepatic immune-related adverse event increased the overall survival of patients with malignancies treated with immune checkpoint inhibitors"".

Tatsuo Kanda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.